EWP
GSK icon

Elevation Wealth Partners’s GSK GSK Stock Holding History

Elevation Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.9K Hold
164
– – ﹤0.01% 976
2026
Q2 		$8.6K Buy
+164
New +$8.67K ﹤0.01% 855

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Elevation Wealth Partners's GSK Position: Q3 2026 in Review

Elevation Wealth Partners held its GSK (GSK) position steady in Q3 2026 at 164 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

Elevation Wealth Partners first reported a position in GSK in Q2 2026 and has held it in 2 quarters since. The position peaked at $8.6K in Q2 2026. 35 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Elevation Wealth Partners held 164 shares of GSK worth $7.9K as of Q3 2026.
  • Elevation Wealth Partners left its GSK share count unchanged in Q3 2026.
  • GSK made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #976 holding.
  • Elevation Wealth Partners first reported a position in GSK in Q2 2026 and has held it in 2 quarters since.
  • Elevation Wealth Partners's GSK position peaked at $8.6K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.